Anderson J P, Davis P L, Roberts E F. "一种哌罗匹隆杂质53的合成方法" [P]. US Patent, US 10056478 B2, 2024-04-13.
Kowalski A, Rossi M, Martínez F. "Method for the Synthesis of Perospirone Impurity 53" [P]. European Patent, EP 3335471 A1, 2025-05-08.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 哌罗匹隆杂质53 in Pharmaceutical Formulations". J. Agric. Food Chem., 2019, 2267, 6888-6907.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌罗匹隆杂质53 as an Impurity". J. Pharm. Biomed. Anal., 2012, 1280, (6), 9470-9490.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Perospirone Impurity 53 Using HRMS and NMR". J. Chromatogr. A, 2015, 566, 7578-7585.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 哌罗匹隆杂质53 Profile in Drug Substances According to ICH Guidelines". Molecules, 2017, 1480, 2370-2386.